Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, Miloslavsky M, Kell S (2006) Dapoxetine Study Group. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 368(9539):929–937PubMedCrossRef

Waldinger MD (2007) Premature ejaculation: definition and drug treatment. Drugs 67:547–568PubMedCrossRef

Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH (2005) Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med 2:498–507PubMedCrossRef

Waldinger MD, Schweitzer DH (2008) The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med 5:1079–1087PubMedCrossRef

Hendriksen H (2012) From nonpharmacological interventions to therapeutic targets for the treatment of PTSD. Dissertation. University of Utrecht, Utrecht. The Netherlands

Pattij T, de Jong T, Uitterdijk A, Waldinger MD, Veening JG, van der Graaf PH, Olivier B (2005) Individual differences in male rat ejaculatory behavior: searching for models to study ejaculation disorders. Eur J Neurosci 22:724–734PubMedCrossRef

Olivier B, Chan JS, Pattij T, de Jong TR, Oosting RS, Veening JG, Waldinger MD (2006) Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Rev Int J Impot Res 18(Suppl 1):S14–S23CrossRef

Waldinger MD (2005) Drug treatment of premature ejaculation: pharmacodynamic and pharmacokinetic paradigms. Drug Discov Today Ther Strat 2:37–40CrossRef

Waldinger MD, Schweitzer DH, Olivier B (2005) On-demand SSRI treatment of premature ejaculation: Pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med 2:120–130